Thank you for helping us #AskPharma to lower the price of the pneumonia vaccine! Over 400,000 people from 170 countries signed our petition, which was handed to Pfizer and GSK in New York, London, and Madrid.

On April 27, 2016, we carried your voices to Pfizer Headquarters, and they accepted our petition. Now, it's their turn to play their role and drop the price of the pneumonia vaccine to $5/child for all developing countries and humanitarian organizations.

Thank you for taking action with us! This campaign is not over, so stay in touch for the next step!

Help us #AskPharma to lower the price of the pneumonia vaccine.





1 million

Nearly 1 million children worldwide die each year due to pneumonia.

$26 billion

Pfizer & GSK have made a total of $26 billion in sales off the pneumonia vaccine.


It now costs 68x more to fully immunize a child now than it did in 2001.


60 countries spoke out about high vaccine prices at the WHA this year.


Pfizer and GSK produce two critical life-saving vaccines against pneumonia. Many lives have been saved by these vaccines, but pneumonia still kills nearly 1 million children every year.

In fact, 75% of children around the world remain unprotected against pneumonia, the leading infectious cause of childhood death worldwide.

You have the power to help change this.

Only about half of the world’s countries have been able to start using the pneumonia vaccines produced by Pfizer & GSK, known as the pneumococcal conjugate vaccine (PCV). One key barrier is the high price.

Even at the lowest global prices, it costs 68 times more today to vaccinate a child in developing countries than it did in 2001 – nearly half of that increase is due to the high price of the pneumonia vaccine alone. This means that a growing number of developing countries can't afford to buy the pneumonia vaccine to protect their children against this childhood killer.

Pfizer & GSK have collectively reported more than US$26 billion in global sales from the pneumonia vaccine. That’s almost three times the entire 20-year budget that Gavi, the Vaccine Alliance, uses to provide 10 different vaccines in around 60 of the world’s poorest countries.

MSF has also struggled to get long-term affordable access to the pneumonia vaccine to help vaccinate some of the world’s most vulnerable children in humanitarian crises.

It's time for Pfizer and GSK to lower the price to $5 per child for all developing countries and humanitarian organizations.

The lowest global price for the pneumonia vaccine is $10 per child, available to only the poorest countries through Gavi. History has shown that with competition, prices will inevitably come down. A producer in India is developing a pneumonia vaccine that it has promised to sell for $6 per child – but it won’t be available until at least 2019. Between now and then, as many as 4 million more children could die because they have not been vaccinated against pneumonia. A more affordable pneumonia vaccine could help reduce this unnecessary loss of life, so why wait any longer to lower the price?

Please, prioritise children's lives over more blockbuster revenues. Today, children are being left unprotected in countries such as Indonesia, Iraq, Jordan, Lebanon, Romania, Syria and Thailand, among many others. A child dies of pneumonia every 35 seconds.

Now's the time to lower the price of the pneumonia vaccine to $5 per child for all developing countries and humanitarian organizations, so more lives can be saved.